Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Renin‐Angiotensin Aldosterone System Inhibitors in Primary Prevention and COVID‐19
Jordan Loader, Erik Lampa, Stefan Gustafsson, et al.
Journal of the American Heart Association (2021) Vol. 10, Iss. 15
Open Access | Times Cited: 11

Showing 11 citing articles:

COVID-19 in dialysis: clinical impact, immune response, prevention, and treatment
Khalil El Karoui, An S. De Vriese
Kidney International (2022) Vol. 101, Iss. 5, pp. 883-894
Open Access | Times Cited: 116
Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research
Jordan Loader, Frances C. Taylor, Erik Lampa, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 11
Open Access | Times Cited: 19
A randomized controlled trial of renin-angiotensin-aldosterone system inhibitor management in patients admitted in hospital with COVID-19
Abhinav Sharma, Malik Elharram, Jonathan Afilalo, et al.
American Heart Journal (2022) Vol. 247, pp. 76-89
Open Access | Times Cited: 15
Inflammation and vascular dysfunction: The negative synergistic combination of diabetes and COVID‐19
Andrea Mario Bolla, Cristian Loretelli, Laura Montefusco, et al.
Diabetes/Metabolism Research and Reviews (2022) Vol. 38, Iss. 7
Open Access | Times Cited: 13
Coagulopathy and thromboembolic events a pathogenic mechanism of COVID‐19 associated with mortality: An updated review
Parastoo Yousefi, Saber Soltani, Goli Siri, et al.
Journal of Clinical Laboratory Analysis (2023) Vol. 37, Iss. 11-12
Open Access | Times Cited: 7
Angiotensin II infusion in COVID‐19: An international, multicenter, registry‐based study
Ary Serpa Neto, Giovanni Landoni, Marlies Ostermann, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 2079-2088
Open Access | Times Cited: 11
Cardiovascular Disease Complicating COVID-19 in the Elderly
Christopher Dayaramani, Joshua De Leon, Allison B. Reiss
Medicina (2021) Vol. 57, Iss. 8, pp. 833-833
Open Access | Times Cited: 12
Initiation of antihypertensive drugs to patients with confirmed COVID‐19—A population‐based cohort study in Sweden
Salar Issa Mousa, Fredrik Nyberg, Mohammadhossein Hajiebrahimi, et al.
Basic & Clinical Pharmacology & Toxicology (2022) Vol. 131, Iss. 3, pp. 196-204
Open Access | Times Cited: 5
Impact of the COVID-19 pandemic on initiation of antihypertensive drugs in Sweden: an interrupted time series study
Ana Tomás, Björn Wettermark, Fredrik Nyberg, et al.
BMJ Open (2024) Vol. 14, Iss. 10, pp. e082209-e082209
Open Access
Steroid hormone receptors and regulation of ACE2 and COVID-19 disease outcomes
Morag J. Young, Karen E. Chapman
Elsevier eBooks (2023), pp. 129-145
Closed Access | Times Cited: 1
The Associations of Antihypertensive Medications, Steroids, Beta Blockers, Statins and Comorbidities with COVID-19 Outcomes in Patients with and without Chronic Kidney Disease: A Retrospective Study
Paul Kim, Vidhya Nadarajan, Maham Ahmed, et al.
COVID (2023) Vol. 3, Iss. 5, pp. 682-692
Open Access
Page 1

Scroll to top